Skip to main content

Cell-to-Cell Transmission of α-Synuclein Aggregates

  • Protocol
  • First Online:
Amyloid Proteins

Part of the book series: Methods in Molecular Biology ((MIMB,volume 849))

Abstract

It is now recognized that the cell-to-cell transmission of misfolded proteins such as α-synuclein contributes to the neurodegenerative phenotype in neurological disorders such as idiopathic Parkinson’s disease, Dementia with Lewy bodies, and Parkinson’s disease dementia. Thus, establishing cell-based models for the transmission of α-synuclein is of importance to understand the mechanisms of neurodegeneration in these disorders and to develop new therapies. Here we describe methods to study the neuron-to-neuron propagation of α-synuclein in an in vitro setting that also has in vivo applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Forman, M.S., Trojanowski, J.Q. and Lee, V.M. (2004). Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10, 1055–63.

    Article  PubMed  CAS  Google Scholar 

  2. Hanger, D.P. and Wray, S. (2010) Tau cleavage and tau aggregation in neurodegenerative disease. Biochem Soc Trans 38, 1016–20.

    Article  PubMed  CAS  Google Scholar 

  3. Hardy, J. (2006). Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 9, 151–3.

    PubMed  CAS  Google Scholar 

  4. Selkoe, D.J. (1994). Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci 17, 489–517.

    Article  PubMed  CAS  Google Scholar 

  5. Goedert, M. (2001). Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2, 492–501.

    Article  PubMed  CAS  Google Scholar 

  6. Goedert, M. (2001). Parkinson’s disease and other alpha-synucleinopathies. Clin Chem Lab Med 39, 308–12.

    Article  PubMed  CAS  Google Scholar 

  7. Ross, C.A. (2004). Huntington’s disease: new paths to pathogenesis. Cell 118, 4–7.

    Article  PubMed  CAS  Google Scholar 

  8. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Rowan, M.J. and Selkoe, D.J. (2002). Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30, 552–7.

    Article  PubMed  CAS  Google Scholar 

  9. Walsh, D.M. and Selkoe, D.J. (2004). Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11, 213–28.

    Article  PubMed  CAS  Google Scholar 

  10. Walsh, D.M. and Selkoe, D.J. (2007). A beta oligomers - a decade of discovery. J Neurochem 101, 1172–84.

    Article  PubMed  CAS  Google Scholar 

  11. El-Agnaf, O.M., Walsh, D.M. and Allsop, D. (2003). Soluble oligomers for the diagnosis of neurodegenerative diseases. Lancet Neurol 2, 461–2.

    Article  PubMed  Google Scholar 

  12. Alvarez-Erviti, L., Rodriguez-Oroz, M.C., Cooper, J.M., Caballero, C., Ferrer, I., Obeso, J.A. and Schapira, A.H. (2010). Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 67, 1464–72.

    Article  PubMed  Google Scholar 

  13. Cherra, S.J., 3 rd, Dagda, R.K. and Chu, C.T. (2010). Review: autophagy and neurodegeneration: survival at a cost? Neuropathol Appl Neurobiol 36, 125–32.

    PubMed  CAS  Google Scholar 

  14. Crews, L. et al. (2010). Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 5, e9313.

    Article  PubMed  Google Scholar 

  15. Cuervo, A.M., Wong, E.S. and Martinez-Vicente, M. (2010). Protein degradation, aggregation, and misfolding. Mov Disord 25 Suppl 1, S49–54.

    Article  PubMed  Google Scholar 

  16. Luo, G.R. and Le, W.D. (2010). Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases. Curr Pharm Biotechnol 11, 180–7.

    Article  PubMed  CAS  Google Scholar 

  17. Matsuda, N. and Tanaka, K. (2010). Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson’s disease? J Alzheimers Dis 19, 1–9.

    PubMed  CAS  Google Scholar 

  18. Aguzzi, A., Sigurdson, C. and Heikenwaelder, M. (2008). Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 3, 11–40.

    Article  PubMed  CAS  Google Scholar 

  19. Caughey, B., Baron, G.S., Chesebro, B. and Jeffrey, M. (2009). Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78, 177–204.

    Article  PubMed  CAS  Google Scholar 

  20. Desplats, P. et al. (2009). Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106, 13010–5.

    Article  PubMed  CAS  Google Scholar 

  21. Kordower, J.H., Chu, Y., Hauser, R.A., Freeman, T.B. and Olanow, C.W. (2008). Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med 14, 504–6.

    Article  PubMed  CAS  Google Scholar 

  22. Lee, H.J., Suk, J.E., Bae, E.J. and Lee, S.J. (2008). Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun 372, 423–8.

    Article  PubMed  CAS  Google Scholar 

  23. Lee, S.J. (2008). Origins and effects of extracellular alpha-synuclein: implications in Parkinson’s disease. J Mol Neurosci 34, 17–22.

    Article  PubMed  CAS  Google Scholar 

  24. Lee, S.J., Desplats, P., Sigurdson, C., Tsigelny, I. and Masliah, E. (2010). Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 6, 702–6.

    Article  PubMed  Google Scholar 

  25. Davidson, W.S., Jonas, A., Clayton, D.F. and George, J.M. (1998). Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273, 9443–9.

    Article  PubMed  CAS  Google Scholar 

  26. Iwai, A. (2000). Properties of NACP/alpha-synuclein and its role in Alzheimer’s disease. Biochim. Biophys. Acta 1502, 95–109.

    PubMed  CAS  Google Scholar 

  27. Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H.A., Kittel, A. and Saitoh, T. (1995). The precursor protein of non-A beta component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467–75.

    Article  PubMed  CAS  Google Scholar 

  28. Weinreb, P.H., Zhen, W., Poon, A.W., Conway, K.A. and Lansbury, P.T., Jr. (1996). NACP, a protein implicated in Alzheimer’s disease and learning, is natively unfolded. Biochemistry 35, 13709–15.

    Article  PubMed  CAS  Google Scholar 

  29. Tsigelny, I.F. et al. (2008). Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer’s and Parkinson’s diseases. PLoS One 3, e3135.

    Article  PubMed  Google Scholar 

  30. Schiesling, C., Kieper, N., Seidel, K. and Kruger, R. (2008). Review: Familial Parkinson’s disease-genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol Appl Neurobiol 34, 255–71.

    Article  PubMed  CAS  Google Scholar 

  31. McKeith, I.G. (2006). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9, 417–23.

    PubMed  Google Scholar 

  32. McKeith, I.G. et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863–72.

    Article  PubMed  CAS  Google Scholar 

  33. Lee, H.J., Patel, S. and Lee, S.J. (2005). Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25, 6016–24.

    Article  PubMed  CAS  Google Scholar 

  34. Lee, H.J. et al. (2010). Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285, 9262–72.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Dr. EM work was supported by NIH grants AG18440, AG022074, NS057096, AG 03097, and AG010435. Dr. SJL work was supported by Mid-career Researcher Program (2010–0015188) and the Diseases Network Research Program (2010–0020610) through NRF grant funded by the Ministry of Education, Science, and Technology.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eliezer Masliah .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Lee, SJ., Desplats, P., Lee, HJ., Spencer, B., Masliah, E. (2012). Cell-to-Cell Transmission of α-Synuclein Aggregates. In: Sigurdsson, E., Calero, M., Gasset, M. (eds) Amyloid Proteins. Methods in Molecular Biology, vol 849. Humana Press. https://doi.org/10.1007/978-1-61779-551-0_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-551-0_23

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-550-3

  • Online ISBN: 978-1-61779-551-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics